Thomas Unise
Medtronic has received FDA clearance for its Stealth AXiS surgical system, an intelligent platform designed to revolutionize spine surgery by integrating planning, navigation, and robotics into one cohesive system.
Key Features and Capabilities
The Stealth AXiS system introduces LiveAlign segmental tracking, a groundbreaking feature that enables surgeons to visualize anatomic motion, surgical adjustments, and patient alignment in real time during spine procedures. This capability eliminates the need for repeated imaging and reduces reliance on manual steps, allowing for more consistent execution of patient-specific surgical plans.
Currently cleared for spine procedures in the U.S., the system’s underlying architecture is designed to support future applications in cranial and ENT surgeries, pending additional FDA clearances.
Clinical Significance
According to Dr. Ronald A. Lehman, Jr., a spine surgery expert at Columbia University and consultant for Medtronic, one of the biggest challenges in spine surgery has been understanding how the spine moves during a procedure. The Stealth AXiS system addresses this by providing real-time visibility into that motion, helping surgeons achieve their surgical plans without disrupting workflow.
Part of a Larger Ecosystem
Medtronic positions the Stealth AXiS as a cornerstone of its MintegratesAiBLE smart ecosystem, designed to enable a more intuitive flow of information across the surgical continuum. The system natively integrates planning, navigation, and execution within a single platform, streamlining workflows and supporting the exchange of insights throughout the surgical process.
Modular Design for Flexibility
Built with versatility in mind, the Stealth AXiS supports a wide range of surgeon preferences, clinical complexity, and care settings. Its modular robotic design allows healthcare institutions to deploy what they need immediately and expand over time as clinical needs evolve, making it suitable for both hospitals and ambulatory surgery centers.
Impact on Surgical Outcomes
Michael Carter, senior vice president at Medtronic Cranial & Spinal Technologies, emphasized that the system aims to make advanced technology more usable and clinically meaningful, helping surgeons deliver more predictable, personalized care while establishing a foundation for continued innovation in addressing the variability challenges in spine surgery.
About Medtronic
Headquartered in Galway, Ireland, Medtronic employs over 95,000 people across more than 150 countries. The company’s Cranial and Spinal Technologies division is a global market leader with 150 products covering more than 20 pathologies, serving over 4 million patients annually. The division’s AiBLE ecosystem integrates advanced technologies, data, and AI with a patient-centric approach to enhance surgical precision and improve outcomes.
GIPHY App Key not set. Please check settings